RM
Ross Moat (CHIEF OPERATING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $9.6M of KNSA (102,863 sh across 10 lots, as filed), executed Oct 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.7M
shares × price, as filed
Last traded
Nov 2
Filed Nov 3
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $13.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$9.6M102,863 sh across 10 lots
Exec Oct 30
Filed Nov 3 · 6:27 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $115K
2,367 sh × $48.58
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $124K
3,523 sh × $35.31
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $801K
27,594 sh × $29.02
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $283K
10,122 sh across 2 lots
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.3M
87,269 sh across 2 lots
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $370K
18,259 sh × $20.29
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET